Últimas noticias sobre Mr. Cooper Gr (NASDAQ:COOP) Bolsa

MR COOPER GROUP INC

Mr. Cooper Gr

Mr. Cooper Group Inc is a home loan servicer. The company focuses on delivering a variety of servicing and lending products. It has operating segments namely Servicing segment which performs operational activities on behalf of investors or owners of the underlying mortgages and mortgage servicing rights, including collecting and disbursing borrower payments, investor reporting, and customer service, The Originations segment originates residential mortgage loans through a direct-to-consumer channel, which provides refinance options for existing customers, and through a correspondent channel, which purchases or originates loans from mortgage bankers and brokers, and the Corporate segment. The Servicing segment of the company generates maximum revenue.

Mr. Cooper Group Inc

Coop Ethereum 2x Index - United States Dollar

Cooper-Standard Holdings Inc. Common Stock

Cooper-Standard Holdings Inc

Oppenheimer analyst Hartaj Singh maintains Sarepta Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) with a Outperform and lowers the price target from $123 to $45.

News

Price Target

Analyst Ratings

SRPT

Oppenheimer Maintains Outperform on Sarepta Therapeutics, Lowers Price Target to $45

The U.S. Food and Drug Administration (FDA) on Friday approved Regeneron Pharmaceuticals Inc.&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) and Sanofi SA&#8217;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNY#NASDAQ">SNY</a>) Dupixent&nbsp;(dupilumab) for adult patients with bullous pemphigoid (BP), a rare, chronic <a target="_blank" href="https://www.benzinga.com/general/health-care" rel="noreferrer noopener">autoimmune skin disorder</a>.
BP primarily affects elderly patients and is characterized by intense itch, painful blisters and lesions, and skin reddening. It can be chronic and relapsing with <a target="_blank" href="https://www.benzinga.com/pressreleases/25/06/g46019439/dupixent-dupilumab-approved-in-the-u-s-as-the-only-targeted-medicine-to-treat-patients-with-bullou" rel="noreferrer noopener">underlying type 2 inflammation</a>.
The blisters and rash can form over much of the body and cause the skin to bleed and break down, making patients more prone to infection.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/05/45692578/regeneron-sanofi-stock-falls-after-uneven-smokers-lung-drug-data" rel="noreferrer noopener">Regeneron, Sanofi Stock Falls After Uneven Smoker&#8217;s Lung Drug Data</a>
The FDA approval is based on data from the pivotal ADEPT Phase 2/3 trial that evaluated the efficacy and safety of Dupixent compared to placebo in adults with moderate-to-severe BP.
Patients were randomized to receive Dupixent 300 mg (n=53) or placebo (n=53) added to standard-of-care oral corticosteroids (OCS).
During treatment, all patients underwent a protocol-defined OCS tapering regimen if control of disease activity was maintained.
The FDA-approved results at 36 weeks in the label for Dupixent compared to placebo are:
<ul class="wp-block-list">
<li>18.3% of patients experienced sustained disease remission compared to 6.1%, the primary endpoint.</li>
<li>38.3% of patients achieved clinically meaningful itch reduction compared to 10.5%.</li>
<li>The median cumulative OCS dose was 2.8 grams compared to 4.1 grams.</li>
</ul>
In this elderly population, the most common adverse events (≥2%) more frequently observed in patients on Dupixent compared to placebo were arthralgia, conjunctivitis, blurred vision, herpes viral infections, and keratitis.
Additionally, one acute generalized exanthematous pustulosis was reported in 1 patient treated with Dupixent and zero treated with placebo.
In April, the FDA approved Dupixent&nbsp;for adults and adolescents aged 12 years and older with chronic spontaneous urticaria (CSU) who remain symptomatic despite histamine-1 (H1) <a target="_blank" href="https://www.benzinga.com/general/biotech/25/04/44931246/regeneron-partners-with-japan-based-fujifilm-to-bolster-us-manufacturing-capacity-via-3-billion-d" rel="noreferrer noopener">antihistamine treatment</a>.
Price Action: REGN stock closed at $513.58 on Wednesday. SNY stock is up 1.45% at $48.31&nbsp;during the premarket session at the last check on Friday.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/health-care/25/06/45724030/kymera-therapeutics-says-atopic-dermatitis-potential-matches-sanofi-regenerons-blockbuster-dupixent-in-early-biomarker-response" target="_blank" rel="noreferrer noopener">Kymera Therapeutics Says Atopic Dermatitis Potential Matches Sanofi/Regeneron&#8217;s Blockbuster Dupixent In Early Biomarker Response</a></li>
</ul>
Image: Shutterstock

Biotech

Large Cap

Health Care

General

REGN

FDA Approves Regeneron Sanofi Treatment For Rare Autoimmune Skin Disorder

A recent call on &#8220;<a href="https://www.youtube.com/watch?v=0mpmCnW2Tmc">The Ramsey Show</a>&#8221; delivered a shocking back-to-back contrast. One caller had just explained how they were surviving on $850 a month. Moments later, a 22-year-old named Zack called in to say he was making between $30,000 and $90,000 a month by day <a href="https://www.benzinga.com/money/futures">trading futures</a>.
<h2 class="wp-block-heading">From Finance Major To Full-Time Trader</h2>
Zack explained that he studied finance at Lipscomb University in Nashville and started trading with just $3,000. &#8220;I decided to use my initial investment for evaluations with a few <a href="https://www.benzinga.com/money/best-prop-trading-firms">prop firms</a>,&#8221; he said. &#8220;You use their capital and get to keep 70 to 90 percent of the profits.&#8221;
Don't Miss:
<ul class="wp-block-list">
<li>Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — <a href="https://www.benzinga.com/money/boxabl-scaling-fast-from-spacex-orders-to-600-homes-built-this-60k-foldable-home-may-be-the-future-of-housing">this is your last chance to become an investor for $0.80 per share.</a></li>
<li>Peter Thiel turned $1,700 into $5 billion—now accredited investors are eyeing this software company with similar breakout potential. Learn how you can <a href="https://www.benzinga.com/money/how-peter-thiel-turned-his-roth-ira-into-5-billion-and-why-accredited-investors-are-now-eyeing-this-smartphone-disruptor">invest with $1,000 at just $0.30/share.</a></li>
</ul>
He's been trading live accounts since February or March and says it only takes him three to four hours a day. &#8220;A bad day would be me breaking even or only losing about a thousand or two,&#8221; Zack said.
George Kamel, one of the co-hosts, asked the obvious question: &#8220;If you&#8217;re so good at this, why not use your own money?&#8221; Zack&#8217;s response came down to caution. &#8220;I was raised a Ramsey kid,&#8221; he said. Instead of using his own money, he <a href="https://www.benzinga.com/money/best-funded-trading-programs">trades with firm capital</a> to avoid personal risk. &#8220;I don&#8217;t have $150,000 I want to invest, and if someone else is going to take on the risk for me&#8230; the less risk and the more success, then that's kind of where I was going with it,&#8221; he added.
<h2 class="wp-block-heading">A Young Trader Thinking Ahead</h2>
Zack said he currently has about $50,000 in liquid savings, no debt, and lives on around $4,000 a month. He also said he&#8217;s putting aside 40 percent for taxes based on advice from his CPA godfather.
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.
Now he wants to <a href="https://www.benzinga.com/money/how-to-invest-in-real-estate">get into real estate</a> and &#8220;maybe do some fix-and-flips.&#8221; However, he wants to do it outside Middle Tennessee, as &#8220;it&#8217;s not cheap right now.&#8221;
Co-host Rachel Cruze jumped in with caution: &#8220;We always say if you&#8217;re going to go beyond your primary residence, you want to do it with cash.&#8221;
She advised Zack to focus on buying a primary residence first and avoid <a href="https://www.benzinga.com/money/how-to-start-flipping-houses-with-no-money">loans for flips</a>, citing how Dave Ramsey himself <a href="https://www.benzinga.com/startups/24/10/41496567/i-splatted-it-hurt-says-dave-ramsey-referring-to-the-sudden-call-on-his-1-2-million-loans-that-turne">went bankrupt</a> by borrowing heavily in real estate. &#8220;That's the wrong way to do it from Ramsey's standpoint,&#8221; she said.
While Zack said he might take out a loan to flip a property and pay it off after the sale, Cruze pushed back: &#8220;Cash is everything,&#8221; with Kamel warning, &#8220;I would not count on this gravy train of day trading for too long.&#8221;
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.</li>
<li><a href="https://www.benzinga.com/money/gbr-savings-by-age">If You're Age 35, 50, or 60: Here&#8217;s How Much You Should Have Saved Vs. Invested By Now</a></li>
</ul>
Image: Shutterstock

A Dave Ramsey Caller Claims To Make $30K–$90K A Month Day Trading. After A Story Of Someone Earning $850 Monthly, The Contrast Was Jarring

<a href="https://tsdr.uspto.gov/#caseNumber=99240420&amp;caseSearchType=US_APPLICATION&amp;caseType=DEFAULT&amp;searchType=statusSearch">https://tsdr.uspto.gov/#caseNumber=99240420&amp;caseSearchType=US_APPLICATION&amp;caseType=DEFAULT&amp;searchType=statusSearch</a>

'Rumble Files For A New Trademark " RUMBLE WALLET" For Crypto Use'

Crocs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CROX#NASDAQ">CROX</a>) has outperformed the market over the past 10 years by 9.94% on an annualized basis producing an average annual return of 20.95%. Currently, Crocs has a market capitalization of $5.62 billion. 
Buying $100 In CROX: If an investor had bought $100 of CROX stock 10 years ago, it would be worth $678.89 today based on a price of $100.23 for CROX at the time of writing.
<h3>Crocs's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750430712_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

CROX

Here's How Much $100 Invested In Crocs 10 Years Ago Would Be Worth Today

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our <a href="https://www.benzinga.com/analyst-stock-ratings">analyst ratings page</a>.
<ul class="wp-block-list">
<li>William Blair analyst Sami Corwin downgraded Sarepta Therapeutics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SRPT#NASDAQ">SRPT</a>) from Outperform to Market Perform. Sarepta Therapeutics shares closed at $20.77 on Wednesday. <a href="https://www.benzinga.com/quote/srpt/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>JMP Securities analyst Mikhail Goberman downgraded the rating for Guild Holdings Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GHLD#NYSE">GHLD</a>) from Market Outperform to Market Perform. Guild Holdings shares closed at $19.72 on Wednesday. <a href="https://www.benzinga.com/quote/GHLD/analyst-ratings">See how other analysts view this stock</a>.</li>
<li>Oppenheimer analyst Noah Kaye downgraded the rating for Johnson Controls International plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) from Outperform to Perform. Johnson Controls shares closed at $103.48 on Wednesday. <a href="https://www.benzinga.com/quote/GHLD/analyst-ratings">See </a><a href="https://www.benzinga.com/quote/JCI/analyst-ratings">how </a><a href="https://www.benzinga.com/quote/GHLD/analyst-ratings">other analysts view this stock</a>.</li>
</ul>
Considering buying SRPT stock? Here&#8217;s what analysts think: 
<figure class="wp-block-image size-large is-resized"><a href="https://www.benzinga.com/quote/SRPT/analyst-ratings"><img loading="lazy" decoding="async" width="1024" height="615" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20104338/image-313-1024x615.png" alt="" class="wp-image-956269" style="width:633px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20104338/image-313-1024x615.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20104338/image-313-300x180.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20104338/image-313-768x461.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/20104338/image-313.png 1133w" sizes="(max-width: 1024px) 100vw, 1024px" /></a></figure>
Read This Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/06/46024423/how-to-earn-500-a-month-from-commercial-metals-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Commercial Metals Stock Ahead Of Q3 Earnings</a> </li>
</ul>
Photo via Shutterstock

Downgrades

Markets

GHLD

This Sarepta Therapeutics Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Friday

Oppenheimer analyst Noah Kaye downgrades Johnson Controls Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JCI#NYSE">JCI</a>) from Outperform to Perform.

Oppenheimer Downgrades Johnson Controls Intl to Perform

<a href="https://www.wsj.com/world/china/u-s-prepares-action-targeting-allies-chip-plants-in-china-10ab18a8">https://www.wsj.com/world/china/u-s-prepares-action-targeting-allies-chip-plants-in-china-10ab18a8</a>

AVGO

NVDA

QCOM

'U.S. Prepares Action Targeting Allies' Chip Plants in China'- WSJ

<a href="https://www.bloomberg.com/news/articles/2025-06-20/european-nations-lead-push-for-de-escalation-in-israel-iran-war-mc4wnjt5?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-20/european-nations-lead-push-for-de-escalation-in-israel-iran-war-mc4wnjt5?embedded-checkout=true</a>

iShares MSCI Israel Capped Investable Market Index Fund

'European Nations Lead Push for De-escalation in Israel-Iran War'- Bloomberg

Pure Storage Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PSTG#NYSE">PSTG</a>) hosted its annual Accelerate event in Las Vegas, where management announced the Enterprise Data Cloud and Pure Fusion with workload automation, according to Needham.
The Pure Storage Grill Analyst: <a href="https://www.benzinga.com/analyst-stock-ratings/analyst/601a8839a6fe6f00010c6966/mike-cikos">Analyst Mike Cikos</a> reiterated a Buy rating and price target of $75.
The Pure Storage Grill Thesis: The company's Enterprise Data Cloud represents a move "from traditionally fragmented storage models to a unified, virtualized data cloud managed by a single control plane across the entire data estate," Cikos said in the note.
Check out <a href="https://www.benzinga.com/analyst-stock-ratings">other analyst stock ratings</a>.
Pure Fusion&#8217;s functionality has been expanded to empower admins to "manage the specific needs of each workload for greater flexibility," he added.
"We continue to view Pure Fusion as a strategic innovation for the company to deliver a Cloud-like experience to customers," the analyst wrote.
Pure Storage also announced several next-generation products that broaden the company&#8217;s addressable market with additional use cases, he further stated.
PSTG Price Action: Shares of Pure Storage had declined by 1.57% to $52.14 at the time of publication on Friday.
Read More: <a href="https://www.benzinga.com/insights/analyst-ratings/25/06/45946624/canaan-stock-a-deep-dive-into-analyst-perspectives-8-ratings"> </a> • <a href="https://www.benzinga.com/insights/analyst-ratings/25/06/45946624/canaan-stock-a-deep-dive-into-analyst-perspectives-8-ratings">Pure Storage Margin To Expand From NAND Pricing Weakness: Analyst</a>
Photo: Tada Images via Shutterstock

Analyst Color

Reiteration

PSTG

Why Pure Storage Analyst Is Bullish On Company's 'Strategic Innovation'

Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>) is approaching a critical support zone, and some traders are calling it one of the best buy-the-dip opportunities before the next move higher.
What Happened: Crypto analyst Pepe is Friend <a href="https://x.com/pepeisfriend/status/1935515872644448273">points</a> out SHIB is trading around $0.00001164, following a 9.33% weekly decline marked by a bearish structure of lower highs and lower lows. Still, the $6.7 billion market cap zone has previously served as strong support (last seen in April 2024), sparking optimism for a bounce or consolidation.
On the upside, the $10 billion market cap, approximately $0.00001696, remains key resistance, a level it failed to break in May 2024. A breakout above this zone could ignite a major leg higher for the meme coin.
The analyst advises, "Stay confident and keep holding, or even buy more SHIB," adding that current prices likely won't last long and that holders "won't regret it." 
Another analyst <a href="https://x.com/thecryptobasic/status/1935608188071821745">cited</a> by The Crypto Basic outlined two paths for Shiba Inu: &nbsp;
<ul class="wp-block-list">
<li>In a bullish scenario, a bounce from current support could push SHIB to $0.00002174–$0.00002418 (up to 100% upside).</li>
<li>And in a bearish scenario, a drop below $0.00001054 could lead to further declines toward $0.00000630.</li>
</ul>
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45939510/shiba-inu-on-verge-of-a-breakout-as-whales-make-bold-moves">Shiba Inu on Verge of a Breakout as Whales Make Bold Moves</a>
Why It Matters: IntoTheBlock data shows Shiba Inu's large transaction volume narrowed by 50.2%, but daily active addresses increased by 30% in a single day. Transactions greater than $100,000 dropped from 48 to 19. On the other hand, Shibariumscan data shows daily transactions increased from 4.59 million to 4.65 million in a single day.
Also, IntoTheBlock data shows that only 10% of SHIB in circulation is in profit, roughly 8.04 trillion tokens (worth around $1.13 billion), while nearly 90% are held at a loss or breakeven, suggesting that selling pressure is already exhausted and accumulation may be underway.
The $0.000011 support level, held by 222,450 wallets owning 43.8T SHIB, is now seen as critical to near-term stability. A break below could spark panic selling, but holding here may trigger a swift reversal.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/45974930/dogecoin-shiba-inu-dip-3-in-a-day-is-a-meme-coin-rally-still-brewing">Dogecoin, Shiba Inu Dip 3% In A Day &#8211; Is a Meme Coin Rally Still Brewing?</a></li>
</ul>
Photo: vlastas on Shutterstock.com

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$SHIB

Shiba Inu Nears Key Support: Trader Urges 'Buy More, You Won't Regret It'

SK Hynix has won <a href="https://www.benzinga.com/topic/chip-stocks" target="_blank" rel="noreferrer noopener">custom high-bandwidth memory</a> (HBM) orders from Nvidia Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>), Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), and Broadcom Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGO#NASDAQ">AVGO</a>). This marks a growing demand as big tech shifts away from general-purpose memory to optimize the performance of its AI services.
HBM chips are&nbsp;a type of computer memory designed for high-performance computing, particularly in graphics processing and AI.&nbsp;They achieve high bandwidth and efficiency by stacking multiple DRAM (Dynamic Random Access Memory) dies vertically, connected via&nbsp;through-silicon vias (TSVs),&nbsp;and using a wide interface.&nbsp;
Also Read: <a href="https://www.benzinga.com/markets/tech/25/06/45906594/micron-and-trump-announce-200-billion-us-chip-expansion-plan-aiming-to-create-90k-jobs" target="_blank" rel="noreferrer noopener">Micron And Trump Announce $200-Billion US Chip Expansion Plan, Aiming To Create 90K Jobs</a>
Contract chipmaker Taiwan Semiconductor Manufacturing Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TSM#NYSE">TSM</a>)&nbsp;will make logic dies for SK Hynix&#8217;s custom HBM.
The South Korean chip supplier prioritized delivery of its leading client, Nvidia, because it was unable to acclimate to the demand frenzy from Big Tech giants, the Korea Economic Daily <a target="_blank" href="https://www.kedglobal.com/korean-chipmakers/newsView/ked202506190003" rel="noreferrer noopener">reported</a> on Thursday.
SK Hynix&#8217;s first custom HBM will be its seventh generation or HBM4E, likely for launch in the second half of 2026.
An <a target="_blank" href="https://www.benzinga.com/government/24/08/40198085/huawei-and-baidu-increase-samsung-hbm-purchases-as-us-curbs-loom" rel="noreferrer noopener">August 2024 report</a> indicated that Chinese technology companies, including&nbsp;Huawei Technologies Co&nbsp;and&nbsp;Baidu Inc&nbsp;(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BIDU#NASDAQ">BIDU</a>), were hoarding HBM semiconductors from&nbsp;Samsung Electronics&nbsp;in anticipation of potential U.S. export restrictions on the chips.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/guidance/25/01/42874446/samsungs-outlook-dims-amid-hbm-supply-struggles-for-nvidia-and-sluggish-consumer-chip-sales" target="_blank" rel="noreferrer noopener">Samsung&#8217;s Outlook Dims Amid HBM Supply Struggles for Nvidia and Sluggish Consumer Chip Sales</a></li>
</ul>
Image: Shutterstock

Tech

Media

BIDU

MSFT

SK Hynix To Supply Next-Gen Memory For Big Tech's AI Push, Prioritizes Nvidia Amid Supply Crunch

Dividends

ATNI

ATN Internation Increases Dividend From $0.24 To $0.275

Rumors

Watching Perimeter Solutions; Hearing Zacks Mentions Stock As A Buy

Brown &amp; Brown (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRO#NYSE">BRO</a>) has outperformed the market over the past 5 years by 7.57% on an annualized basis producing an average annual return of 21.42%. Currently, Brown &amp; Brown has a market capitalization of $35.75 billion. 
Buying $100 In BRO: If an investor had bought $100 of BRO stock 5 years ago, it would be worth $262.59 today based on a price of $108.40 for BRO at the time of writing.
<h3>Brown &amp; Brown's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1750429818_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much $100 Invested In Brown & Brown 5 Years Ago Would Be Worth Today

U.S. stocks were mixed, with the Dow Jones index gaining over 50 points on Friday.
Shares of The Kroger Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KR#NYSE">KR</a>) rose sharply during Friday's session after the company reported <a href="https://www.benzinga.com/quote/KR/earnings">better-than-expected first-quarter adjusted EPS results.</a>
Kroger reported quarterly earnings of $1.49 per share which beat the analyst consensus estimate of $1.46 per share. The company reported quarterly sales of $45.12 billion compared to the analyst consensus estimate of $45.19 billion.
Kroger shares climbed 7.1% to $70.11 on Friday.
Here are some other big stocks recording gains in today&#8217;s session.
<ul class="wp-block-list">
<li>Gorilla Technology Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRRR#NASDAQ">GRRR</a>) shares jumped 35% to $25.41 following a robust first-quarter earnings report that showed significant revenue growth and a return to profitability.</li>
</ul>
<ul class="wp-block-list">
<li>Couchbase, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) gained 30.9% to $24.78 as the company agreed to be acquired by Haveli Investments for $1.5 billion.</li>
<li>GMS Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GMS#NYSE">GMS</a>) rose 29% to $104.44 following a report suggesting Home Depot made an offer to acquire the company. QXO reportedly submitted an unsolicited offer to buy the company.</li>
<li>Liminatus Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LIMN#NASDAQ">LIMN</a>) gained 22.2% to $15.70.</li>
<li>Wheels Up Experience Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UP#NYSE">UP</a>) surged 19.9% to $1.5350.</li>
<li>Oscar Health, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/OSCR#NYSE">OSCR</a>) gained 18.6% to $22.30 after gaining more than 16% on Wednesday.</li>
<li>Zeta Global Holdings Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZETA#NYSE">ZETA</a>) rose 18% to $14.86.</li>
<li>New Fortress Energy Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NFE#NASDAQ">NFE</a>) gained 15.8% to $2.4909.</li>
<li>Circle Internet Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRCL#NYSE">CRCL</a>) rose 15.7% to $231.12 after Seaport Global initiated coverage on the stock with a Buy rating and announced a $235 price target.</li>
<li>Centrus Energy Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LEU#NYSE">LEU</a>) gained 15.3% to $208.66. Centrus Energy secured $110 million DOE contract extension to produce HALEU through June 2026, with an option for 8 more years.</li>
<li>GXO Logistics, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GXO#NYSE">GXO</a>) gained 11.8% to $47.85. GXO announced Patrick Kelleher as Chief Executive Officer.</li>
<li>Metsera, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTSR#NASDAQ">MTSR</a>) rose 9.7% to $30.38. Wells Fargo analyst Cerena Chen initiated coverage on Metsera with an Overweight rating and announced a price target of $65.</li>
<li>Under Armour, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UAA#NYSE">UAA</a>) rose 9.6% to $6.76.</li>
<li>AST SpaceMobile, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTS#NASDAQ">ASTS</a>) gained 8% to $47.88.</li>
<li>CarMax, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KMX#NYSE">KMX</a>) rose 5% to $67.50 after the company reported better-than-expected first-quarter financial results. Also, the company reported an increase in quarterly retail used unit sales, comparable store used unit sales and wholesale units sales.</li>
</ul>
Now Read This: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/dividends/25/06/46024423/how-to-earn-500-a-month-from-commercial-metals-stock-ahead-of-q3-earnings">How To Earn $500 A Month From Commercial Metals Stock Ahead Of Q3 Earnings</a> </li>
</ul>
Photo via Shutterstock

Intraday Update

Movers

ASTS

BASE

CRCL

GRRR

LIMN

MTSR

OSCR

ZETA

Kroger Posts Better-Than-Expected Earnings, Joins Couchbase, CarMax And Other Big Stocks Moving Higher On Friday

INLF

INLIF LIMITED Shares Resume Trade

Mizuho analyst Maheep Mandloi maintains Array Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARRY#NASDAQ">ARRY</a>) with a Neutral and raises the price target from $8 to $9.

ARRY

Mizuho Maintains Neutral on Array Technologies, Raises Price Target to $9

Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) is <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46023419/bitcoin-ethereum-xrp-dogecoin-hold-steady-no-top-in-sight-plenty-of-room-to-grow">trading in a range</a>, with sudden drops triggering losses for long-position traders. Despite this, bullish sentiment remains strong, supported by solid underlying fundamentals across the broader crypto market.
What Happened: On-chain tracker Lookonchain in an X <a href="https://x.com/lookonchain/status/1934993227565965671">post</a> on June 20 noted that ByBit's top trader AguilaTrades has gone long on Bitcoin once again, opening a massive 3,854 Bitcoin position worth $408 million, currently showing $3.2 million in unrealized gains.
AguilaTrades previously suffered $15.4 million in losses within 10 days, after failing to lock in profits. The trader&#8217;s most recent position flipped from a $10 million unrealized gain to a $2.5 million drawdown, echoing a previous trade where a $5.8 million profit reversed into a $12.47 million loss.
Now operating on Hyperliquid, where the trader moved after raking in $77.36 million in profits on ByBit in 2023, AguilaTrades is trading with 20x leverage and a liquidation price of $103,330. Will AguilaTrades finally take profits this time or repeat past mistakes in a bid to dominate Hyperliquid?
Also Read: <a href="https://www.benzinga.com/crypto/cryptocurrency/25/06/46023419/bitcoin-ethereum-xrp-dogecoin-hold-steady-no-top-in-sight-plenty-of-room-to-grow">Bitcoin, Ethereum, XRP, Dogecoin Hold Steady: No Top In Sight, &#8216;Plenty Of Room To Grow&#8217;</a>
Why It Matters: Aguila's aggressive reentry comes as macro sentiment turns bullish for crypto. El Salvador is expanding Bitcoin adoption with new BTC/USD kiosks at its main airport and spot Bitcoin ETFs continue to attract strong institutional inflows. Today's Bitcoin options expiry, with $5.8 trillion in open contracts, is expected to exert upward pressure on the crypto&#8217;s price.
Santiment <a href="https://x.com/santimentfeed/status/1935810125656191139">data </a>points out that Bitcoin wallets are showing a divergence between whales and retail. Whale wallets (10+ BTC) increased by 231 in the last 10 days, while Retail wallets (0.001–10 BTC) decreased by 37,465 in the same period.
On-chain data suggests that this divergence, where whales accumulate while retail exits, has historically signaled an upcoming bullish momentum in crypto markets. With Bitcoin trading above $104,300, the setup resembles past phases before major rallies.
What's Next: Crypto trader BitBull sees Bitcoin following the classic Power-of-3 market structure — accumulation continued from Jan.–Feb. 2025, manipulation entered from March–April 2025, and expansion, which is currently underway.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><a href="https://twitter.com/search?q=%24BTC&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$BTC</a> Power-of-3 pattern formation &#x1f440; ➙ Accumulation happened during Jan/Feb 2025 ➙ Manipulation happened during March/April 2025 ➙ And now, BTC is in the expansion phase. Options expiry is happening today, both in crypto and stocks. So, I&#39;m expecting a few more days of… <a href="https://t.co/ykJyjewRVV">pic.twitter.com/ykJyjewRVV</a>
&mdash; BitBull (@AkaBull_) <a href="https://twitter.com/AkaBull_/status/1935994453786771806?ref_src=twsrc%5Etfw">June 20, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
BitBull predicts that post-options expiry, a few more days of consolidation will pave the way for a volatile breakout, with price targets between $130,000 and $135,000.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/crypto/25/06/46011285/bitcoin-could-pop-120-in-2025-to-205097-if-current-growth-cycle-indicator-is-anything-to-go-by-says-this-analyst">Bitcoin Could Pop 120% In 2025 To $205,097 If Current Growth Cycle Indicator Is Anything To Go By, Says This Analyst</a></li>
</ul>
Photo: sundaemorning on Shutterstock

$BTC

Bitcoin Veteran Trader Goes Long Again After $15 Million In Losses — Will Third Time Be The Charm?

Deutsche Bank analyst Krisztina Katai maintains Nike (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NKE#NYSE">NKE</a>) with a Buy and lowers the price target from $77 to $71.

Deutsche Bank Maintains Buy on Nike, Lowers Price Target to $71

Press Releases

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OPTN, COOP, MESA on Behalf of Shareholders

Mr. Cooper Group Inc. to Release First Quarter 2025 Financial Results on April 23, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, MHLD, LTRPA on Behalf of Shareholders

Legal

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, OPTN, AZEK, MESA on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates COOP, MESA, DADA on Behalf of Shareholders

Mr. Cooper Group Reports First Quarter 2025 Results

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PRA, COOP, MESA on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TASK, PRA, COOP on Behalf of Shareholders

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates RDUS, COOP, ICAD, PULM on Behalf of Shareholders

AZEK

COOP

DADA

ICAD

LTRPA

MESA

MHLD

OPTN

PULM

RDUS

TASK

Enact Holdings

Federal Agricultural Mortgage Corporation Common Stock

Federal Agricultural

Better Home & Finance Holding Company - Class A Common Stock

Better Home & Finance

Essent Group

Finance of America Companies Inc. Class A Common Stock

Finance of America

Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Comments

Mr. Cooper Gr

Noticias

Últimas noticias sobre Mr. Cooper Gr (NASDAQ:COOP) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL